Magnetar Financial
ORIAW

Magnetar Financial’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Magnetar Financial’s Portfolio ORIAW Stock Details ORIAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-69,500
Closed -$12K – 1224
2022
Q3 		$12K Buy
+69,500
New +$15.1K ﹤0.01% 1128

Other funds holding ORIAW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
GAM
Gritstone Asset Management Bethesda, Maryland $104M AUM 6.03% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Magnetar Financial's ORIAW Position: Q4 2022 in Review

Magnetar Financial sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q4 2022, closing a stake of 69,500 shares — an estimated $12K sold.

Magnetar Financial first reported a position in ORIAW in Q3 2022 and held it in 1 quarter. The position peaked at $12K in Q3 2022. 29 funds tracked by Wall St. Rank hold ORIAW as of Q4 2022.

  • Magnetar Financial reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q4 2022 after selling out during the quarter.
  • Magnetar Financial sold 69,500 Orion Biotech Opportunities Corp. Warrant shares in Q4 2022, an estimated $12K.
  • Magnetar Financial first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2022 and held it in 1 quarter.
  • Magnetar Financial's Orion Biotech Opportunities Corp. Warrant position peaked at $12K in Q3 2022.
  • 29 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q4 2022.

Based on Magnetar Financial's 13F filing for Q4 2022, filed 14 Feb 2023.